Resistell News:

TOP 100 SWISS STARTUP AWARD

newsimage
newsimage
Resistell News:

TOP 100 SWISS STARTUP AWARD

For the first time Resistell with its Rapid AST made it to TOP100 this year! We are super proud and have big ambitions to climb up the list! Stay tuned!
curves

Latest news

28th March 2019

Resistell selected as one of 10 Winners of Venture Leaders Life Sciences

Resistell was selected as one of ten new startups have been selected for Venture Leaders Life Sciences 2019. Chosen from among the most-promising life sciences startups in Switzerland, the team will embark on a packed, week-long roadshow in Boston. The startups will also pitch at the Startup Champions Seed Night event in Lausanne on 11 April.
25th March 2019

Join us at The Economist Antimicrobial Resistance Summit on 26.03.2019 in London

"Enough time has been wasted issuing warnings about antibiotic resistance. The moment has come to do something about it” The Economist
18th March 2019

The 50 Swiss startups in which to invest in 2019

Bilan selected Resistell as one of the Top 50 Swiss startups in which to invest in 2019! We are proud to be on the prestigious list with our rapid AST technology!
news image news image
18th March 2019

Resistell presented the science behind the rapid AST method during the AMR Berlin 2019 conference

We thank everyone who visited our scientific presentation in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (14-15.03.2019). We are looking forward to all new future partnerships and collaborations!
news image news image
13th March 2019

Meet us it Berlin at Novel Antimicrobials and AMR Diagnostics 2019

We invite you to meet us in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (14-15.03.2019). For more details please visit https://amr-conference.com
news image news image
27th December 2018

Resistell wins 3rd stage of VentureKick

The jury of industry experts and investors selected Resistell to receive the highest level of Venture Kick’s financial support to bring their businesses to market.
12th December 2018

Resistell closes the seed financing round

Resistell has closed an oversubscribed seed financing round. Lead Investor Occident Group AG, Hemex AG and six other private investors invested in the EPFL spin-off developing the world’s fastest phenotypic antibiotic susceptibility test.